Definitive Contract HHSN272201400002C

Award Date 12/6/13
Potential Completion Date 6/5/19
Potential Value $11M
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
San Francisco, CA 94118, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $2,464,113 definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Wisconsin System to conduct research on "Characterizing and Improving Humanized Immune System Mouse Models (IMM-HIS)". The contract has no set-aside designation. The University of Wisconsin System is performing this work with subcontractors from the University of Calgary, The Morgridge...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract, valued at $659,747.55, was awarded to the University of Texas Health Science Center at San Antonio (UTHSCSA) to provide animal models of infectious diseases. This contract is a delivery order under NIAID's larger "Animal Models of Infectious Diseases 2010-2017" indefinite delivery vehicle (IDV), which has a potential...
The Department of Health and Human Services National Institutes of Health awarded a definitive, cost-no-fee contract to The Regents of the University of California, San Francisco (UCSF) for $6,657,300.68. The contract is for biomedical (basic) services and does not have a set-aside designation. UCSF, a public academic medical center and research university, is providing services through its Controller's Office division. The contract commenced on September 30, 2004 and is scheduled for completion...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to The University of Texas Health Science Center at San Antonio (UTHSCSA) for the provision of animal models of infectious diseases. The contract has a ceiling value of $695,479.00 and an ultimate completion date of August 22, 2018. This delivery order is part of a larger indefinite delivery/indefinite quantity (IDIQ)...
This is a $2,907,745 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of North Carolina at Chapel Hill (UNC-CH) to characterize and improve humanized immune system mouse models for infectious disease research. The contract supports NIAID's efforts to develop medical countermeasures against emerging infectious diseases and antimicrobial resistance. The contract was awarded under NIAID's $146.3 million single-award...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Health Science Center at San Antonio (UTHSCSA) to provide pre-clinical models and testing services for the development of medical countermeasures against viral, bacterial, and fungal pathogens. The contract is an indefinite delivery vehicle (IDV) valued at up to $146.3 million over 7 years, under which...
This firm fixed price delivery order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to The Research Foundation for the State University of New York. The $832,888 contract is for the development of xenograft mouse models to study varicella zoster virus and human cytomegalovirus. This work is being performed under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery,...
This federal contract award, valued at $12,612,049, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to the University of Pittsburgh. The contract is for research and development related to infectious disease models, including the provision of small animal models, non-human primate models, animal replacement models, and specialized reagents. This contract is part of a larger $146.3 million...
This is a definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services' National Institutes of Health (NIH), to Diadexus, Inc., a for-profit manufacturer, for AIDS research activities. The contract has a potential value of $80,286,861.00 and a completion date of April 3, 2007. The contract was awarded on September 30, 2003 and does not have a set-aside designation. The place of...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...

This is a $10,521,865.50 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to The Regents of the University of California, San Francisco (UCSF) for the development of humanized mouse models for HIV therapeutics. The contract, which does not have a set-aside designation, supports research and development focused on advancing new treatments for HIV/AIDS. As a leading academic medical center and research institution, UCSF has a strong track record of collaborating with federal agencies like NIAID on cutting-edge biomedical research initiatives. The contract work is expected to be completed by June 5, 2019.

Generated 9/17/24, 9:59 AM